Pain Mechanism Research Articles
This chapter provides an analysis of the differences between nociception and pain, on the idea of the
anatomy of the peripheral and central nervous systems and therefore the role of nociceptors in pain perception. It includes discussion of the concept of persistent pain and presents
information on the embryologic origins of pain. Finally it addresses the modulatory role of hysteria, fear, and
stress on pain. Pain may be a product of upper
brain center processing, whereas nociception can occur within the absence of pain. For instance , the medulla spinalis of a private who suffered an entire medulla spinalis transection can still process
information transmitted by nociceptors, but because the knowledge can't be transmitted beyond the transection stimulus-evoked pain is unlikely. The anatomical basis for the generation of momentary pain is extremely well understood (Basbaum and Jessell 2000). Nociceptors are unusual
neurons because they need a cell body with a peripheral axon and terminal (ending) that responds to the stimulus and a central branch that carries the knowledge into the CNS. Briefly, there are two major classes of nociceptors that answer different modalities of noxious stimuli. The second major nociceptor population is related to thinly myelinated axons (A-delta fibers). These nociceptors conduct sooner than do unmyelinated C-fibers and certain convey “fast” (or sharp) momentary pain, as against slow, diffuse pain, which is transmitted by the C-fibers.
High Impact List of Articles
-
The nocebo effect: should we be worried?
Luana Colloca
Editorial: Clinical Investigation
-
The nocebo effect: should we be worried?
Luana Colloca
Editorial: Clinical Investigation
-
Stem cell clinical trials: toward cell-based therapy for retinal degenerations
Henry Klassen
Editorial: Clinical Investigation
-
Stem cell clinical trials: toward cell-based therapy for retinal degenerations
Henry Klassen
Editorial: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ecallantide for the treatment of acute attacks of hereditary angioedema due to C1-inhibitor deficiency
Jonathan Bernstein, Joseph Biedenkapp
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
New advances in the diagnosis and treatment of pediatric tuberculosis
Andrea T Cruz, Anna M Mandalakas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
Relevant Topics in Clinical